Abstract
Introduction
Enteric fever is an important public health problem caused by salmonella species (typhoidal group) Salmonella enteric serovar typhi, Paratyphi A, Paratyphi B and Paratyphi C. WHO estimates 21.7 million cases every year with 217,000 deaths1. Without treatment enteric fever has a mortality rate of 30% if appropriately treated with the sensitive antibiotic, the mortality can be reduced to below 0.5%1. With the emergence of multi drug resistance Salmonella i.e Resistance to ampicillin, chloramphenicol and Co-trimoxazole, Fluroquinolones were being used (i.e Ciprofloxacin) or Ceftriaxone for the treatment of enteric fever1,2. With the extensive use of Fluroquinolones, Salmonella species are less susceptible to Ciprofloxacin (with the MIC of Nalidixic acid ≥32 µg/ml and that of ciprofloxacin ≤0.25µg/ml) emerged. Some strains of Salmonella especially Salmonella enteric serovar para typhi A shows resistance to Ciprofloxacin with MIC of ≥1 µg/ml also with the use of Ceftriaxone, it is found that slowly the time taken for fever defervesce is increasing.
References
1. Harish BN, Menezes GA. Antimicrobial resistance in typhoidal salmonellae. Indian J Med Microbiol 2011; 29:223-9.
2. Hohmann EL. Nontyphoidal Salmo-nellosis. Clin Infect Dis 2001, 32:263-9.
3. Butler T, Sridhar CB, Daga MK, et al. Treatment of typhoid fever with azithromycin versus chloramphenicol in a randomized multicentre trial in India. J AntimicrobChemother. 1999;44:243–50. [PubMed]
4. Chinh NT, Parry CM, Ly NT, et al. A randomized controlled comparison of azithromycin and ofloxacin for treatment of multidrug-resistant or nalidixic acid-resistant enteric fever. Antimicrob Agents Chemother.2000;44:1855–9
5. AshwiniChoudhary, Ram Gopalakrishnan, Nambi P. Senthur, V. Ramasubramanian, K. Abdul Ghafur, and M.A. Thirunarayan* Antimicrobial susceptibility of Salmonella enterica serovars in a tertiary care hospital in southern India. Ind J Med 137,April2013. PP800-802
6. Garg A1, Verma S, Kanga A, Singh D, Singh B. Antimicrobial resistance pattern and in-vitro activity of azithromycin in Salmonella isolates. Indian journal of medical microbiology (2013) 31(3); 287-289.
7. Marcus Ho Yin Wong, MeiyingYan , Edward Wai Chi Chan and Sheng Chen et.al. Emergence of Clinical Salmonella entericaserovartyphimurium isolates with concurrent resistance to Ciprofloxacin, Ceftriaxone and Azitromycin (july 2014) Volume 58 number 7.
8. Erika R.Vliegheetal, Thong Phe et.al, Birgit De Smet et.al, ChhunH.Veng et.al, Chun Kham et.al, Sophie Bertrand et.al, Raymond Vanhoof et.al, Lut Lynen et.al, Willy E.Peetermans et.al and Jan A.Jacobs et.al. Azithromycin and Ciprofloxacin resistance in Salmonella Blood stream Infections in Camboidan adults.
9. Sreenivasan Sririangaraj et.al, Arunava Kali et.al and M.V Pravin Charles et.al. Astudy of antibiogram of Salmonella enterica serovar Typhi isolates from Pondicherry, India.
Corresponding Author
Sumana M N
Professor and Head
Department of Microbiology, JSS Medical College & Hospital, Mysore
DOI: https://dx.doi.org/10.18535/jmscr/v5i6.97
